Navigation Links
Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
Date:11/4/2008

SAN DIEGO, Nov. 4 /PRNewswire/ -- Accumetrics, Inc. announces the appointment of William H. Dippel to the position of Executive Vice President of Operations and R&D. Mr. Dippel will oversee the Operations, Research and Product Development departments at Accumetrics.

"We are excited to have Bill join our team," said Timothy Still, President and Chief Executive Officer of Accumetrics. "Bill's 33 years of operations and R&D experience in the healthcare industry will be a tremendous asset to Accumetrics."

Prior to joining Accumetrics, Mr. Dippel was Vice President of Operations at Barrx Medical, Inc. Before joining Barrx, Mr. Dippel was Executive Vice President of HemoSense, Inc., responsible for R&D, Manufacturing, Engineering, Materials, and Facilities Management. He provided strong leadership introducing lean manufacturing resulting in improvements in gross margin, and later played a key role during the acquisition of HemoSense by Inverness Medical Innovations.

Prior to that position, Mr. Dippel was Vice President of Operations for Micro Therapeutics -- eV3. Earlier in his career, Mr. Dippel was with Conceptus, Inc. as Vice President of R&D and Operations, and PercuSurge (now a division of Medtronic, Inc.) as Vice President of Operations and held senior positions with Boehringer Mannheim GmbH (now Roche Diagnostics), Ciba Corning Diagnostic Corporation and Spectrum Technology, Inc.

Mr. Dippel holds a B.S. in Mechanical Engineering from the California State Polytechnic University, Pomona, California.

About Accumetrics

Accumetrics is committed to advancing medical understanding of the platelet function and enhancing the quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow(R) System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis.

Contact:

Jules Abraham

Lippert/Heilshorn & Associates

212-838-3777

jabraham@lhai.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. Novo Nordisk Appoints New Leader of North American Business
3. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
4. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
5. Resonant Medical Appoints New Vice President of Global Sales
6. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
7. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
8. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
9. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
10. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
11. Adlyfe Appoints Roxanne Duan as Vice President of Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... WASHINGTON D.C. (PRWEB) , ... July 25, 2017 ... ... therapists and their clients, today announced it will be exhibiting and providing demos ... Convention at the Walter E. Washington Convention Center in Washington D.C. from August ...
(Date:7/25/2017)... ... July 25, 2017 , ... USHEALTH Group, Inc. has ... prestigious CEO World Awards®. The coveted annual CEO World Awards program encompasses the ... studies, corporate social responsibility, and milestones from every major industry in the world. ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... SignatureCare ... scholarship will be awarded for the fall semester to a deserving student. Get ... Centers Spring 2017 scholarship was awarded to Mariana Castillo who is a nursing student ...
(Date:7/24/2017)... Peru (PRWEB) , ... July 24, 2017 , ... ... for $1,000 total in scholarship awards to be awarded annually to and divided ... demonstrate an interest in bringing awareness to Amazonian plant medicine. To apply for ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... two organizations that already work hand-in-hand on an Innovation Collaboration program, have signed ... access, quality, experience and cost of the care members and patients receive. The ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... -- Eli Lilly and Company (NYSE: LLY ) has ... pending patent litigation in the U.S. District Court for the ... Cialis ® (tadalafil) unit dose patent. This patent was ... of the agreement, Cialis exclusivity is now expected to end ... unit dose patent for Cialis is valid and infringed by ...
(Date:7/11/2017)... -- Dr. Echenberg, founder of Echenberg Institute, is announcing a new safe and ... painful intercourse and other painful pelvic pain conditions such as pelvic floor ... ... ... -based start-up company, VuVatech LLC, fills a void in the women,s ...
(Date:7/10/2017)...  The tenth annual BioPharm America™ will ... at the Sheraton Boston Hotel, September 26–27. The event ... decision makers and innovative biotech startup companies. The event ... two impactful days. BioPharm America is now part of ... opportunities with 4,500+ life science industry influencers participating in ...
Breaking Medicine Technology: